MARY DOTSON: Open Payments
NPI 1508977240 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 33 payments from 11 companies in 2025. Trend: 2023 $1,067 · 2024 $835 · 2025 $836
Food & beverage: $743Education: $93
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $277 |
| Regeneron Healthcare Solutions, Inc. | 6 | $177 |
| Janssen Biotech, Inc. | 2 | $96 |
| GENZYME CORPORATION | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Ipsen Biopharmaceuticals, Inc | 2 | $42 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Organon LLC | 1 | $20 |
Products named: DUPIXENT, LINZESS, TREMFYA, SKYRIZI, MAVYRET, IQIRVO, RINVOQ, ZENPEP.
Industry payments across GA — which companies pay providers there.
